Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial.
Thibault
Vincent
V
Delaugerre
Constance
C
Calvez
Vincent
V
Costagliola
Dominique
D
Tubiana
Roland
R
Katlama
Christine
C
D015658:HIV Infections / Q000150:complications*; D016174:Hepacivirus / Q000502:physiology*; D006509:Hepatitis B / Q000150:complications / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology*; D006526:Hepatitis C / Q000150:complications / Q000821:virology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects*
D007376:Interleukin-2